# Scott J. Rodig

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/scott-j-rodig/

## Facts

| Field | Value |
| --- | --- |
| Citations | 79,262 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 130 |
| i10-index | 359 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5058975989 |
| ORCID iD | https://orcid.org/0000-0003-1761-9769 |
| Works | 1,536 |

## Researcher papers

- [Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>](https://scholariq.org/papers/clinical-features-and-outcome-of-patients-with-non-small-cell-lung-cancer-who/)
- [Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints](https://scholariq.org/papers/adaptive-resistance-to-therapeutic-pd-1-blockade-is-associated-with-upregulation/)
- [Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors](https://scholariq.org/papers/activation-of-the-pd-1-pathway-contributes-to-immune-escape-in-egfr-driven-lung/)
- [Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors](https://scholariq.org/papers/genomic-correlates-of-response-to-immune-checkpoint-blockade-in-microsatellite/)
- [Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1](https://scholariq.org/papers/association-of-polymerase-e-mutated-and-microsatellite-instable-endometrial/)
- [Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems](https://scholariq.org/papers/expansion-sequencing-spatially-precise-in-situ-transcriptomics-in-intact/)
- [Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels](https://scholariq.org/papers/association-of-high-tumor-mutation-burden-in-non-small-cell-lung-cancers-with/)
- [Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial](https://scholariq.org/papers/neoadjuvant-and-adjuvant-pembrolizumab-in-resectable-locally-advanced-human/)
- [The Neuroblastoma-Associated F1174L ALK Mutation Causes Resistance to an ALK Kinase Inhibitor in ALK-Translocated Cancers](https://scholariq.org/papers/the-neuroblastoma-associated-f1174l-alk-mutation-causes-resistance-to-an-alk/)
- [Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses](https://scholariq.org/papers/tumor-innate-immunity-primed-by-specific-interferon-stimulated-endogenous/)
- [Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade](https://scholariq.org/papers/therapeutically-increasing-mhc-i-expression-potentiates-immune-checkpoint/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.